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Abstract
The main purpose of this thesis was to evaluate the potential of pectins from the Malian medici-
nal tree Cola cordifolia used in the treatment of gastric ulcer and wounds. This thesis is a small
contribution to the ultimate goal of providing efﬁcient none-toxic and inexpensive medicines
for the Malian population.
The Department of Traditional Medicine, our collaborating partner in Bamako, wants to pro-
mote the use of renewable plant parts to guarantee a sustainable supply of medicinal plants.
The structures and biological activities of the bark and leaf pectins were therefore compared
in order to make recommendation on plant part substitution as debarking can damage or even
kill the tree. We found that the pectins from the bark and leaves are structurally related. How-
ever, the leaf pectins are more polydisperse and heterogeneous compared to the pectins found
in bark. Pectins from the bark were generally more active in the complement ﬁxation test and
the macrophage assay. Comparing the 50°C water extracts from bark and leaf in an experi-
mental anti-ulcer model showed comparable and dose dependent inhibition of ulcer formation.
However, a clinical trial is needed to evaluate the efﬁcacy of the plant parts.
Powdered roots of Vernonia kotschyana are highly valued as the improved traditional medicine
“Gastrosedal”. The anti-ulcer activity of the medicine has previously been attributed to the
presence of saponins. In this thesis, the anti-ulcer potential of 50°C and 100°C water extracts
depleted of saponins, but high in inulin, 98% and 83% respectively, were evaluated in an ex-
perimental mouse model. The tested dose corresponded to the recommended daily intake of
“Gastrosedal” and this dose showed a good inhibition of ulcer formation. We therefore con-
cluded that inulin can also be responsible important for the anti-ulcer activity of “Gastrosedal”.
In Mali, gastric ailments are rather common and contribute highly to morbidity in the country.
In a previous study, Helicobacter pylori was found to be present in 95% of Malian patients with
gastric ulcer. For future investigations and clinical trials, it was of interest to ﬁnd a reliable and
simple method for H. pylori detection. One stool and one serological based immunochromato-
graphic method were tested, and the results showed that the sensitivity of these tests is too low
in the Malian population. The low sensitivity was probably due to strain variability, in addition
to high use of anti-malaria drugs, which might eradicate or lower the bio-burden of H. pylori.
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1. Introduction
Traditional medicine is deﬁned as the sum total of knowledge, skills and practices based on
the theories, beliefs and experiences, indigenous to different cultures, that are used to maintain
health, as well as to prevent, diagnose, improve or treat physical and mental illnesses (WHO,
2008). In most countries traditional medicine is better known under names like complementary,
alternative or non-conventional medicine. However, for most developing countries traditional
medicine is not an alternative, but the main supply of medicine for the population’s primary
health care. According to World Health Organization (WHO), 75% of the Malian population
depends on traditional medicines and the interest in traditional medicine is growing (Robison
& Zhang, 2011; Diallo & Paulsen, 2000). Mali is a poor and underdeveloped country, ranked
as number 175 of 187 countries in the human development report of 2011 (Klugman, 2011).
Hence the use of expensive imported medicines is difﬁcult for most of the population, and it is
therefore important that traditional medicine is used complementary to western medicines. In
addition, Mali has a limited number of physicians, 1 for every 16 000, and a poorly developed
infrastructure, especially in remote areas, which makes transportation of medicines difﬁcult,
thus resulting in low availability (Diallo & Paulsen, 2000). In 1994, a devaluation of the local
currency happened over night, and the cost of the imported medicines doubled. Hence, western
medication does not provide a medical system that is sufﬁcient by its own due to the price, but
must be acting side by side with traditional medicine. The traditional practitioners are higher in
numbers, reaching 1 for every 500, and they diagnose and treat patients in addition to providing
them with cheap and available traditional medicines. However, clearly, traditional medicine is
not sufﬁcient by itself to treat all conditions.
The best way of giving the population an appropriate primary health care is to assure that tradi-
tional medicine is used complementary to western medicine by developing more efﬁcient and
safe improved traditional medicines (ITMs). For this purpose the Department of Traditional
Medicine (DMT), located in the capital Bamako in Mali, was established. DMT is now a col-
laborating center of WHO with the primary objective to establish a mechanism to assure that
traditional medicine produced from local plants is complementary to western medicine. To
achieve this goal, DMT is collaborating with the traditional practitioners. This collaboration is
based on trust and the common goal to improve the health condition in the country and increase
the knowledge on medicinal plants.
For the aim of learning more about the use of medicinal plants, several ethnomedical studies
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have been carried out, especially in the period from 1968-1992 (Diallo & Paulsen, 2000). Tra-
ditional practitioners are the main informants of the DMT in the development of ITMs and for
the basis of the ethnopharmacological studies. Studies on safety and efﬁcacy of the traditional
medicine are maintained by ethnopharmacological research which will provide additionally evi-
dence for the uses, resulting in more reliable medicines. An ethnopharmacological investigation
is, by deﬁnition, observation, identiﬁcation, description and experimental investigation of the
ingredients and the effects of indigenous drugs (Holmstedt & Bruhn, 1983). It is a truly in-
terdisciplinary ﬁeld of research which is important in the study of traditional medicine. So far,
DMT has developed twelve ITMs and seven of them are regarded as essential medicines in Mali
(Willcox et al., 2012).
Typically, many types of molecules in the same plant are contributing to the observed biological
activity. The most common way of preparing the traditional medicine is by making a decoction.
Polar and semi polar low molecular weight substances like steroids, terpenes, alkaloids and
phenolic compounds will together with macromolecules, like polysaccharides, be extracted into
the boiling water. Normally, only the low molecular weight compounds are studied. However,
polysaccharides are shown to possess immunomodulating properties which make them highly
interesting as possible active substances in traditional medicine.
1.1 Plant polysaccharides
Polysaccharides are an important class of mainly plant derived polymers including cellulose,
hemicellulose, pectins, starch and inulin. Their function in the plant is usually either structure
or storage related. The molecular composition and arrangement in the plants differ among plant
species.
Pectins are the most structurally complex family of polysaccharides in nature. They are found
in the primary cell wall, as an interpenetrating matrix supporting cellulose microﬁbriles, to-
gether with hemicellulose and proteins. The precise chemical structure of pectin is under de-
bate, although the structural elements of pectin are rather well described, see Fig. 1.1 (Coenen
et al., 2007). Pectins are galacturonic acid-rich polysaccharides including homogalacturonan,
rhamnogalacturonan I and the substituted galacturonans; rhamnogalacturonan II (RG-II) and
xylogalacturonan (XGA). It is generally believed that the HG, RG-I and RG-II are covalently
cross-linked since harsh chemical treatments or digestion by pectin-degrading enzymes are re-
quired to separate (Ridley et al., 2001; Mohnen, 2008).
The most abundant pectic polysaccharide is homogalacturonan (HG), a linear homopolysac-
charide consisting of (1→4) α-galacturonans. Some of the carboxyl groups may be methyl-
esteriﬁed, and depending on the source, the galacturonic acid (GalA) residues can also be acety-
lated in position 2 or 3. The methyl esteriﬁcation might be present as blocks or the substitution
may be randomly distributed. HG has been shown to be present in stretches of approximately
100 GalA residues in length (Yapo et al., 2007).
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Rhamnogalacturonan-I (RG-I) comprises a highly diverse population of developmentally reg-
ulated polymers (Willats et al., 2001). RG-I is a group of pectic polysaccharides that contains
a backbone of the repeating disaccharide →4)αGalA(1→2)-α-L-Rha-(1. The Rha residues are,
depending on the plant source, substituted at C-4 with neutral and acidic mono or oligosac-
charides. The highly branched nature of RG-I has made it known as the “hairy region” of the
pectin, in contrast to HG domains which are known as the smooth regions. The side chains
of RG-I can be arabinans, arabinogalactans, galactans or monomers of different types, see Fig.
1.2. Arabinans have a 1→5 linked arabinose backbone, with branching points consisting of
1→2,5 or 1→3,5 linked arabinose linked via O-2 or O-3, respectively, to linear arabinose side
chains of varying size. Pure galactans consist of 1→4 linked galactose. Arabinogalactans can
be divided into two subclasses, arabino-4-galactans (AG-I) and arabino-3,6-galactans (AG-II).
AG-I has a 1→4 linked Gal backbone with branching via O-3 to linear arabinans of various
size. AG-II is more complex compared to AG-I and can be highly branched with 1→3,6 linked
Gal as branch points. AG-II has a galactan backbone consisting of 1→3 linked Gal as the main
chain and often 1→6 linked Gal as side chains. Ara can be bound to O-3 or O-6 of Gal depend-
ing on where Ara is situated. The side chains may also contain terminal α-Fuc, β-GlcA, and
4-O-Me-β-GlcA residues (Mohnen, 2008). In addition the side chains can be esteriﬁed with
ferulic acid (Ridley et al., 2001).
Rhamnogalacturonan-II (RG-II) is a low molecular mass (5–10 kDa) pectic polysaccharide
with a highly conserved sequence across plant species. The name RG-II is somewhat mislead-
ing, because it suggests that this structure contains a rhamnogalacturonan backbone like RG-I,
but RG-II has a 1→4-linked GalA backbone. Two structurally distinct disaccharides and two
oligosaccharides are attached the backbone, see Fig. 1.1 (Perez et al., 2003).
Inulin belongs to a class of dietary ﬁbers known as (2→1)-β-fructans with a degree of polymer-
ization (DP) up to 100, and each chain can be terminated by a single glucose unit, depending
of the type (Kelly, 2008). Inulin is typically found stored in roots or rhizomes as a source of
energy (comparable to starch). Plants that store inulin, does normally not store starch. Plant
families that normally store inulin are Asteraceae and Liliaceae.
1.2 Pectins as immunomodulators
The ability to modulate the immune response in an appropriate way can enhance the host’s im-
mune responses (Tzianabos, 2000). Polysaccharides capable of interacting with the immune
system to up or down regulating speciﬁc aspects of the host response can be classiﬁed as im-
mune modulators. Although few types of pectins have been rigorously studied, reports have
revealed some of the structure-activity relationship of these molecules.
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Figure 1.1: Schematic structure of pectin showing the four pectic polysaccharides homogalac-
turonan (HG), xylogalacturonan (XGA), rhamnogalacturonan I (RG-I) and rhamnogalacturonan
II (RG-II) linked to each other. The representative pectin structure shown is not quantitatively
accurate. From Mohnen (2008).
Figure 1.2: A model showing the major structural features of rhamnogalacturonan I. The back-
bone is composed of the disaccharide repeating unit [→4-α-D-GalpA-(→2)-α-L-Rhap-(1→].
Branched and linear oligosaccharides composed predominantly of α-L-Araf and β-D-Galp
residues are linked to C4 of some of the Rhap residues. Some of the Rhap residue may also be
O-acetylated at C2 and/or C3. More than ten glycosyltransferase activities are required for the
biosynthesis of RG-I. From Ridley et al. (2001).
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Figure 1.3: Overview of complement activation and function. The three known pathways that
activate the complement cascade join at the formation of a C3 convertase. This complex cleaves
C3 into components C3a and C3b, ultimately leading to pathogen opsonization, release of in-
ﬂammatory mediators, and formation of terminal complement components. From Janeway et al.
(2005).
1.2.1 Complement system
The complement is a cascade system of at least 20 serum glycoproteins that provides many
of the effector functions of humoral (soluble factors) immunity and inﬂammation, including
vasodilation, increased vascular permeability, phagocytosis and lysis of foreign cells. The com-
plement plays an important role in the ﬁrst line defense against infections and it holds important
effector functions of the innate and the adaptive immune system. The complement is activated
through the classical, mannose binding (lectin) or the alternative pathway, see Fig. 1.3. The
classical pathway links to the adaptive immune system through binding of C1q to the Fc region
of immune complexes. The alternative pathway is continuously and spontaneously activated in
the blood, where C3b binds to hydroxyl groups (from carbohydrates) on the surface of bacteria
and human cells. As C3b is randomly deposited, human cells have regulating proteins on their
surface inactivating the cascade, see Fig. 1.3 (Janeway et al., 2005).
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It has been known for almost 40 years that complex polysaccharides can activate the comple-
ment (Snyderman & Pike, 1975). Pectins have been shown to activate the complement through
the classical and alternative pathway. It is possible to distinguish between the classical and
the alternative pathway, as the classical pathway requires both calcium and magnesium ions,
whereas the alternative pathway requires magnesium ions only. Selective chelation of calcium
ions in serum can be used to block the classical complement pathway while leaving the alter-
native pathway intact (Snyderman & Pike, 1975). The alternative pathway is inactivated by
dilution of the complement source. Method A (Michaelsen et al., 2000) uses a 1:70 dilution of
serum which results in inactivation of the alternative pathway. There is not much information
about activation of pectins through the mannose binding pathway. However, PM-II, an acidic
pectic polysaccharide form Plantago major, did not activate the mannose-binding lectin path-
way (unpublished results, personal communication Michaelsen, T). The experiment was carried
out with a complement source from a person with an inactive mannose pathway and compared
with results carried out with serum from a person with a functional mannose pathway.
The complement ﬁxation assay does not discriminate between activation and inhibition of the
complement cascade because both result in inhibition of hemolysis (Alban et al., 2002). To
distinguish between activation and inhibition it is possible to use ELISA methods for detection
of C3 activation products (Michaelsen et al., 2000). A simple method to distinguish activation
and inhibition is simply to vary the incubation time. While activation requires time for building
the cascade, inhibition happens immediately and it is therefore possible to distinguish the two
mechanisms simply by omitting pre-incubation (Alban et al., 2002). The basic mechanism of
the pectic polysaccharides reported in the literature seems to be complement activation (Alban
et al., 2002).
Structure- activity studies suggest that the hairy regions of RG-I, with complex galactan or
AG-II side chains attached are important for complement activity (Paulsen & Barsett, 2005;
Yamada & Kiyohara, 2007). The size of these structures may also be important (Pangburn,
1989). Homogalacturonan regions of pectins found in Angelica acutiloba are shown to have an
inhibiting or modulating activity of complement, see Fig. 1.4 (Yamada & Kiyohara, 2007).
1.2.2 Macrophage stimulation
Monocytes in the blood inﬁltrate and take residence in tissue and differentiate into macrophages.
Their role is to remove microorganisms during infections and cellular and particle debris, in
addition to interact with and stimulate lymphocytes (Janeway et al., 2005). Plant polysaccha-
rides are shown to interact speciﬁcally with pattern recognition receptors on macrophages via
complement receptor 3 (CR3), mannose receptor (MR), scavenger receptor (SR), Dectin-1 or
Toll-like receptor 4 (TLR4) (Schepetkin & Quinn, 2006). Plant polysaccharides can also be
phagocytosed, leading to activation of unknown intracellular targets. Speciﬁcally, TLR4 has
been identiﬁed as a receptor for acidic plant-derived polysaccharides (Kim et al., 2007). Bind-
ing to TLR4 leads to the activation of transcriptional pathways leading to the production of
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Figure 1.4: Structure requirements for complement activation of pectins from Angelica acu-
tiloba. From Yamada & Kiyohara (2007).
pro-inﬂammatory cytokines and inducible nitric oxide synthase (Schepetkin & Quinn, 2006).
In addition, complement activation can lead to activation of macrophages through complement
receptors expressed on the surface of the phagocytes, see Fig. 1.5.Inngjerdingen et al. (2008)
suggested that the presence of RG-I with AG-II side chains is part of the structural requirement
of macrophage activation and that RG-II rich fractions did not activate macrophages.
1.3 Internal and external wounds
1.3.1 Gastric ulcer and H. pylori infection
H. pylori is recognized as major risk factor for developing gastritis and gastric ulcer. Infections
with H. pylori are found worldwide in individuals of all ages, but are commonly acquired at an
earlier age in developing countries (Wang & Peura, 2011). Individuals may be asymptomatic
carriers of the disease, but the presence of H. pylori is highly correlated with underlying ail-
ments causing dyspepsia. A previous study conducted in Mali on patients with gastric ulcer
reported a H. pylori prevalence of 95% (Mourtala, 2000). In Mali, the prevalence of gastric
ulcer in the population is reported to be 4.2% for men and 2.4% for women, and is probably
higher for gastritis (Touré, 1989; Maïga et al., 1995).
H. pylori is a non-invasive gram negative bacteria which uses locomotion to penetrate the vis-
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Figure 1.5: Schematic model illustrating potential signalling pathways involved in macrophage
activation by botanical polysaccharides. From Schepetkin & Quinn (2006).
cous mucosa layer where it adheres to the mucus and colonizes. Soluble surface constituents,
like LPS provoke pepsinogen release and trigger local inﬂammation. Urease, a soluble sur-
face protein, is the primary chemoattractant to activate inﬂammatory cells, which again will
release cytokines to promote inﬂammation. Anti-H. pylori antibodies (IgA and IgG) will often
cross-react with glandular cells in the stomach, leading to destruction of gastric epithelia and
ulceration. Unfortunately, presences of antibodies after H. pylori eradication do not provide
protection towards re-infection. The bacteria also contribute, through a complex mechanism, to
increased gastrin levels in the blood, which again contribute to a lower pH in the gastric ﬂuid. A
low pH contributes probably to the formation of metaplasia which again will increase the prob-
ability of getting gastric cancer. The presence of cytotoxin producing H. pylori is much higher
in patients with ulcers (70%) than in patients with a silent infection (30%). It might seem that
an active ulcer can modify the activity of H. pylori (Halter et al., 1992).
The currently most effective treatment for peptic ulcer disease is a triple therapy regimen con-
sisting of a proton pump inhibitor, such as omeprazole, and two antibiotics, clarithromycin and
either amoxicillin or metronidazole. However, there is an increase in antibiotic resistance and
in all countries, and unfortunately reinfection happens fast in countries with a high prevalence
(Hunt et al., 2010). For patients with severe ulcer and symptoms, conventional medicine is
probably the best solution, but traditional medicine can provide pain relief from symptoms and
give the patients a better quality of life.
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Figure 1.6: The pathogenesis of ulcer formation and healing, and the mechanism of how
polysaccharides prevent ulcer induction through free radical scavenging, reduction of neutrophil
inﬁltration and promotion of ulcer healing by stimulation of cell migration, proliferation and an-
giogenesis at the ulcer site. From Cho & Wang (2002).
1.3.2 Anti ulcer activity in in vivo experimental models
Immunomodulating polysaccharides from various plants have shown dose-dependent anti-ulcer
activity in gastric lesions induced by necrotizing agents in experimental anti-ulcer models (Mat-
sumoto et al., 2002; Nergaard et al., 2005a; Cipriani et al., 2008, 2009). Anti-ulcer activity of
acidic pectins from Bupleurum falciparum was reduced after pectinase treatment, indicating that
HG regions are important for activity. Apple pectins consisting of 95% GalA showed no sig-
niﬁcant activity, indicating that the hairy regions are also important for activity (Yamada et al.,
1991). A direct correlation between immunomodulation and anti-ulcer activity of pectins has
not been found.The mechanisms behind the anti-ulcer activity of acidic pectins from Bupleu-
rum falciparum are suggested to be mucosal protective coating, anti-secretory activity of gastric
acid and pepsin, in addition to radical scavenging activity. The mechanism did not involve en-
dogenous prostaglandin production or increased mucus synthesis (Sun et al., 1991; Matsumoto
et al., 1993). See Fig. 1.6 for an overview of possible mechanisms of how polysaccharides can
prevent peptic ulcer formation.
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1.3.3 Anti-adhesive activity towards H. pylori
H. pylori infection is initiated by adhesion to the gastric epithelia of the host. Adhesion is
mediated by lectins bound to the surface of the bacteria. The lectins bind to complementary
carbohydrates on the surface of the host tissue, and the bacteria can start colonizing at the ad-
hesion site. To block tissue adhesion and colonization, soluble complementary polysaccharides
like pectins can be administrated. These carbohydrates can bind to the bacterial lectins, which
will lead to blocking of the adhesion site of the bacteria (Sharon & Ofek, 2002). Previously it
has been shown that acidic polysaccharides from immature okra (Abelmoschus esculentus) in-
hibited adhesion of H. pylori to human gastric mucosa, but the polysaccharides were ineffective
in an in vivo study of infected chicken broilers due to metabolism in the gastrointestinal system
(Wittschier et al., 2007). The structure important of in vitro inhibition is mainly highly charged
pectins, with glucuronic acid as the main uronic acid. Anti-adhesive drugs are postulated to only
be used prophylactic as a dissociation of bacteria already in the state of adherence with the host
tissue seems unlikely (Wittschier et al., 2007). Prophylactic use as a diet or in health promoting
food could only be successful if the active compounds are not degraded in the gastrointestinal
system.
1.3.4 Wound healing
In developing countries like Mali, injuries leading to wounds occur during farming activities.
Numerous plants are used for the treatment of wounds (Diallo et al., 2002).
The complexity of wound healing is a major problem when studying wound healing activities in
vitro. Wound healing is an complex interplay between residential and inﬁltrating immune cell
types and it may be divided into four phases: (i) coagulation and haemostasis; (ii) inﬂamma-
tion; (iii) proliferation; and (iv) wound remodelling with scar tissue formation (Burd & Huang,
2008). As wound healing is an immune-mediated process, it is possible that agents modulating
the immune function, like pectins, have an effect on the reparative process. Immunomodulating
pectins can be important in activation of macrophages, direct or through activation of the com-
plement system, and has been shown in some model systems to contribute to wound healing
(Werner & Grose, 2003; Rizk et al., 2004). Chronic ulcers are known to have reduced levels
of platelet derived growth factor, basic ﬁbroblast growth factor, epidermal growth factor, and
transforming growth factor β compared with acute wounds (Harding et al., 2002). All of these
growth factors are expressed by activated macrophages. Pectins with macrophage stimulating
activity might therefore modulate the regenerative process of healing of chronic wounds. In ad-
dition, polysaccharides can have a direct keratinocyte proliferative activity, as seen by pectins
from Plantago major in an in vitro scratch assay (Zubair et al., 2012). Nutrition is also an im-
portant parameter to consider in wound healing. Lack of proteins and vitamin A and vitamin
C is often correlated with a slow healing (MacKay & Miller, 2003). Since Mali is a one of the
poorest countries in the world, nutritional status is often poor. The fruit of C. cordifolia contains
vitamin C (Diop et al., 1988), and can in this regard help people with a low vitamin C status.
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Figure 1.7: Cola cordifolia (Cav.) R. Br. (Malvaceae). The local name is N'tabanokò.
1.4 Cola cordifolia (Cav.) R.Br (Malvaceae)
According to The Plant List (2012) Cola cordifolia (Cav.) R. Br. has recently changed family
from Sterculiaeae to Malvaceae. C. cordifolia grows on the savannah in Senegal to Mali (West
Africa) and is a large tree ranging between 15 and 25 m in height. It has a short buttressed
trunk, low-branching and a dense crown, see Fig. 1.7 (Burkill, 2000). In Bamako, merchants
are often seen trading their goods in the shadow provided by the tree. The mature fruit is edible
and is a source of vitamin C (Diop et al., 1988). All parts of the tree (roots, leaves, bark and
seeds) are used in traditional medicine. In Mali, the bark and leaves are used to treat different
types of wounds and stomach problems, pain, fever and diarrhea (Grønhaug et al., 2008; Togola
et al., 2008; Austarheim et al., 2012). In an extensive survey of wound healing plants in the
Bamako region, 123 species were identiﬁed, and C. cordifolia was among the ﬁfteen most cited
wound healing plants identiﬁed (Diallo et al., 2002). Previously, anti-ulcer activity was reported
from related species like Cola acuminata (Diallo et al., 1999). Burkill (2000) reports a wide
use of the tree, treating ailments like chest affections, constipation, wounds and leprosy among
others. In Senegal, the bark is used to treat bronchitis, abscesses and gangrene (Kerharo &
Adam, 1974). According to Grønhaug et al. (2008), the two most common ways of preparing
the traditional medicine were decoction and preparation of a powder. The decoction was used
for a bath and/or to drink. The powder was suspended in water and used for a bath and/or as a
drink, or it was thrown into ﬁre and the smoke was inhaled.
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Figure 1.8: Vernonia kotschyana roots and ﬂowers.
1.5 Vernonia kotschyana Sch. Bip. ex Walp (Asteraceae)
The plant Vernonia kotschyana Sch. Bip. ex Walp. (Asteraceae) was renamed according to
The Plant List (2012) to Vernonia adoensis var. kotschyana (Sch.Bip. ex Walp.) G.V.Pope.
However, the ﬁrst name is used throughout this thesis, since the new name has never been cited
in the scientiﬁc literature and it is an unresolved name. Unresolved names are highly likely
to be changed in the future (The Plant List 2012). V. kotschyana is a shrub growing in the
savannah from Senegal to Nigeria across Africa to Ethiopia, see Fig. 1.8 (Burkill, 2000). V.
kotschyana is highly valued in Mali (West-Africa) for the treatment of gastritis, stomach ulcers
and wounds (Diallo et al., 2002; Willcox et al., 2012). The powdered roots of V. kotschyana
are commercially available as an ITM, sold under the name “Gastrosedal”. “Gastrosedal” is
on the national list of essential drugs in Mali for treatment of gastritis and gastric ulcers. The
efﬁcacy of the medicine has been evaluated in two (uncontrolled) clinical trials. The ﬁrst being
an open clinical trial with 16 outpatients with gastric ulcers, 50% of the patients were relieved
of symptoms and in 6 patients lesions had disappeared after ingestion of 6g powdered roots per
day for 30 days (Touré, 1989). One year later, 47 patents with gastric ulcer were enrolled; 80%
reported symptomatic improvement (Diallo et al., 1990). Furthermore, the herbal medicine also
shows good tolerability in Irwing screening and in the brine shrimp assay (Sanogo et al., 1996).
An experimental anti-ulcer rat model on various extracts from V. kotschyana roots showed a
high protective activity. It was suggested that the steroidal saponins was the active principle
(Germano et al., 1996; Sanogo et al., 1996). However, since the roots contain a high amount
of inulin and immunomodulating pectins (Nergaard et al., 2005b,c), these compounds are also
suggested to explain parts of the activity of the plant.
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2. Aims of the study
The ultimate goal for the research presented in this thesis is to provide efﬁcient, non-toxic,
available and affordable medicines to the population of Mali. The plants chosen for this thesis
are Cola cordifolia and Vernonia kotschyana. These two plants, especially the latter, have long
traditions in the treatment of wounds and gastric ulcers. Decoctions (hot water extracts) of these
plants are commonly used preparations, and as plant polysaccharides are readily extracted into
the decoction, it is highly relevant to examine for bioactive polysaccharides.
The speciﬁc objectives of the study were:
1. Compare the structure and immunomodulating activity of polysaccharides present in the
bark and leaves of C. cordifolia to investigate whether or not plant part replacement can
be recommended (Paper I and II).
2. To study the anti-ulcer activity in experimental rodent models of polysaccharide rich ex-
tracts from bark and leaves of C. cordifolia and the roots of V. kotschyana (Paper III and
IV).
3. To perform ethnopharmacological surveys in order to provide more information on the
traditional use of C. cordifolia (Paper III).
4. To ﬁnd a simple method for H. pylori detection for further research on gastric ailments in
Mali (Paper V).
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3. Summary of papers
Paper I. Chemical and biological characterization of pectin-
like polysaccharides from the bark of the Malian medicinal
tree Cola cordifolia
The aim of the paper was to isolate and study the structure of pectins from the bark of C. cordi-
folia. In addition, the complement and macrophage activating properties of the pectin fractions
were evaluated. A 50°C water extract was prepared from de-fatted C. cordifolia bark powder.
The extract was fractionated on an ion exchange column to provide three fractions, CC1, CC2
and CC3. Unexpectedly, CC1 did not attach to the column despite a 47% uronic acid content.
Interfering divalent ions were removed and CC1 was further puriﬁed to give CC1P1 and CC1P2.
Structure elucidation was carried out by GC, GC/MS, SEC-MALLS, IR and NMR, which gave
the structure of the relatively homogeneous CC1P1, 2→[α-D-Gal(1→3)]α-L-Rha(1→4)α-D-
GalA(1→], with a molecular weight of Mw 135 kDa and a polydispersity index of 1.2. The
presence of α-linked Gal and 1→2,3 linked Rha are unusual in RG-I structures. CC1P2 (1400
kDa), contained the same backbone, but in addition to T-α-Gal, α-4-OMe-GlcA and α-2-OMe-
Gal were found as terminal units. CC1P1 shows a high complement-ﬁxing activity, ICH50 being
2.2 times lower than the positive pectin control PMII (ICH50 appr. 71 μg/ml) while ICH50 of
CC1P2 was 1.8 times lower. The simple structure of CC1P1 did not activate macrophages,
while CC1P2 (100 μg/ml) showed the same potency as the positive controls PMII (100 μg/ml)
and LPS (500 ng/ml). No cytotoxicity was detected.
Paper II. Chemical and biological characterizations of pectins
from Cola cordifolia leaves
The main goal of this study was to investigate the structure-activity relationship of the pectins
present in the leaves of C. cordifolia. A 50% EtOH, in addition to a 50°C and 100°C water
extracts, named LCC50%, LCC50 and LCC100 respectively, were prepared from de-fatted C.
cordifolia powdered leaves. Due to a high initial viscosity, LCC50 was not further fraction-
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ated. LCC50% and LCC100 were fractionated by ion-exchange chromatography, giving the
fractions denominated LCC50%A and LCC100A. These two fractions were fractionated on a
MonoP column gave rise to heterogeneous and polydisperse fractions with Mw between 3 and
1300 kDa. Most fractions contained branches attached to O-3 of Rha and GalA. This suggests
highly branched polymers with short side chains. Free acidic oligosaccharides (<3kD) con-
sisting of 41% T-4-OMe-GlcA, 20% GalA, 5.6% Xyl, in addition to Ara, Rha and Gal were
present in some of the fractions. Oligosaccharide analysis on a HPAEC-PAD showed three
major oligomeric fragments (<3 kDa). The pectin fractions did not induce macrophages. How-
ever, all fractions showed complement ﬁxing activity comparable to our positive control, acidic
pectin from Plantago major, PMII. By comparing the pectins from the bark and leaves, we
observe a structural relationship when it comes to molecular weight, types of side chains and
linkages. The complement modulating and macrophage activating activities, which are thought
to be important for the traditional use, are apparently lower for leaf pectins compared to bark
pectins. LCC100A (from leaf) and CC1 (from bark) did not show any anti-adhesion towards
H. pylori, and it was therefore concluded that the pectins does not possess anti-ulcer activity by
hindering H. pylori attachment to the mucus.
Paper III. Anti-ulcer polysaccharides from Cola cordifolia bark
and leaves
The main objective of this paper was to evaluate and compare the in vivo anti-ulcer activity of
the leaves and bark from C. cordifolia. De-fatted, powdered, bark and leaves of C. cordifolia
were extracted with 50°C water and subsequently characterized by GC, Yariv-precipitation and
quantiﬁcation of phenolic compounds. The bark contained more 2-OMe-Gal and less GalA
compared to the leaves. Phenolic compounds were measured to be 2.2% (bark) and 18.8%
(leaves), and both extracts were AG-II positive. Gastric ulcers were induced in rats by admin-
istrating 90% EtOH by gavage one hour after administration of the 50°C water extracts (0, 50
or 200mg/kg b.w.). The inhibition of ulcer formation was calculated based on lesion index (the
sum of the lengths of all ulcers). The results showed that the bark and the leaves comprise a dose
dependent anti-ulcer activity in (no statistical difference between the plant parts). To acquire
more knowledge about the traditional use, an ethnopharmacological investigation was carried
out including 26 traditional practitioners in Siby (a village near Bamako). Pain and wounds
were the most cited indications.
Paper IV. Inulin-rich fractions from Vernonia kotschyana roots
have anti-ulcer activity
The aim of this study was to evaluate the anti-ulcer potential of inulin rich extracts from roots of
V. kotschyana. Previously, the anti-ulcer activity shown by V. kotschyana was attributed solely
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to the saponins present. De-fatted root powder was extracted with 50°C water and subsequently
with 100C water to give Vk50-I and Vk100-I. An inulin content of 98% and 83%, respectively,
were found. In addition to inulin, Vk100-I contained approximately 15% pectins and minor
amounts of phenolic compounds and proteins. Saponins were not detected. Vk50-I and Vk100-
I were administrated 50 minutes before induction of gastric ulcers in mice with 0.3 M HCl-60%
EtOH. Inhibition of ulcer formation was calculated based on lesion index. Vk50-I and Vk100-I
signiﬁcantly inhibited the formation of gastric lesions in mice in the concentration 100 mg/kg
b.w. which corresponds to a daily intake of 15 g dried roots. In addition to the direct ulcer
inhibiting ability, it is possible that water soluble polysaccharides have an indirect impact on
the general health of the GI. Immunological activities were measured by complement ﬁxation
and macrophage activation. Vk50-I and Vk100-I did not show any activity in the mentioned
assays. In addition, a simple toxicity study was carried out on brine shrimps which showed that
toxic components were not present.
Paper V. Chromatographic immunoassays for H. pylori detec-
tion – are they reliable enough in Mali (West Africa)?
The aim of the paper was to ﬁnd a simple method for H. pylori detection in addition to under-
stand more about gastrointestinal (GI) related problems in Mali. H. pylori is often associated
with GI diseases which are major reasons for morbidity in Mali. Twenty-nine volunteers with
conﬁrmed gastric ulcer by gastroscopy and 59 randomly selected volunteers were diagnosed by
using the rapid serological test Clearview® H. pylori. The ImmunoCard STAT!® HpSA® test
was applied on stool from 64 volunteers seeking help for gastrointestinal related ailments. An
H. pylori prevalence of 20.7% was found among the individuals with conﬁrmed gastric ulcer,
44% among the randomly selected volunteers and 13.4% in individuals with gastrointestinal
related ailments. According to what is already known about the etiology of gastric ailments
and the prevalence of H. pylori in neighboring countries, the infection rates in our study appear
strikingly low. This might indicate that Clearview® H. pylori and ImmunoCard STAT!® HpSA®
have low sensitivities in the populations studied. Strain variability and use of anti-malarial drugs
may be an explanation. The tests need to be properly evaluated in Mali before they can be relied
upon as diagnostic tools.
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4. Results and discussion
4.1 Ethnopharmacological research (Paper III)
During the years 1998-2008 four ethnopharmacological surveys on the medicinal tree, Cola
cordifolia, were carried out in Siby, Dioila and the Dogonland (Diallo et al., 2002; Grønhaug
et al., 2008; Togola et al., 2008, Paper III). The ﬁrst study, Diallo et al. (2002), identiﬁed
C. cordifolia as one of the ﬁfteen most cited wound healing plants (out of 123 plants) in the
Bamako region. It was therefore of interest to acquire more knowledge about the use of this
particular tree. In 2008, Togola et al. reported that the tree was used against abdominal pain,
wounds and fever, while Grønhaug et al. (2008) reported pain, fever and diarrhea as the main
areas for treatment. In the third paper of this thesis (Paper III), the most cited indications were
pain and wounds/dermatitis. The ethnomedical information obtained from the three studies
Figure 4.1: The combined ethnomedical results of C. cordifolia bark and leaves.
mentioned above (Diallo et al., 2002; Grønhaug et al., 2008; Togola et al., 2008, Paper III) was
combined in Fig. 4.1. The results showed that there was not a big difference in the traditional
uses between the leaves and bark. Similarities in the use of the two plant parts indicate that
plant part substitution should be possible.
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Figure 4.2: Map of Mali. The village Siby lies 50 km southwest of the capital, Bamako. The
surveys of Grønhaug et al. (2008) were carried out in Siby and Dioila. The study of Togola
et al. (2008) was carried out in Dioila and Dogonland, and the study in Paper III was carried
out solely in Siby.
The main way of preparing the medicine of the two plant parts in the three surveys was extrac-
tion with boiling water (decoction). In addition to low molecular weight polar and semi-polar
substances like alkaloids, saponins and ﬂavonoids, also high molecular weight substances like
polysaccharides are extracted by the hot water. For healing of wounds and gastric ulcers, it is
probably highly relevant to look for potentially active polysaccharides as these molecules can
have an immunomodulating activity in addition to adhering to the surface of the wound and
have an effect as protecting remedy.
4.2 Isolation and puriﬁcation of the pectic polymers
Water soluble polysaccharides from C. cordifolia described in Paper I and II were extracted
and puriﬁed according to the ﬂow schemes, see Fig. 4.3. Water extracts for the anti-ulcer
experiments in rat and mouse models in Paper III and IV were puriﬁed according to the ﬂow
scheme in Fig. 4.4. CCbark50 and CCleaf50 in Fig. 4.4 must not be confused with any of the
fractions in Fig. 4.3.
Initial investigations of the polysaccharides isolated from the bark of C. cordifolia have previ-
ously been carried out by Togola et al. (2008) and Næss (2003). They found that a 50°C water
extract was more active in the complement ﬁxing test compared to the 100°C water extract. It
was therefore decided to focus on the 50°C water extract in Paper I.
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Figure 4.3: Fractionation scheme of C. cordifolia bark and leaves as described in Paper I and II.
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Figure 4.4: Extraction and puriﬁcation of water extracts used for experimental anti-ulcer model
(Paper III and IV).
The polysaccharides from leaves (Paper II) had not been investigated before, and it was there-
fore decided to extract the leaves with 50% EtOH, 50°C and 100°C water. The polysaccharide
rich fractions obtained were named LCC50%, LCC50 and LCC100 respectively. LCC50 had a
similar monosaccharide composition as LCC100, but was even more viscous. It was therefore
decided not to further purify the 50°C leaf extract, see Fig. 4.3.
Papers III and IV focus on the anti-ulcer activity of pectins from the bark and leaves from C.
cordifolia and the roots from V. kotschyana, respectively. Since we were primarily interested
in the medical activities contributed by the pectins present, the plant materials were de-fatted
with organic solvents prior to water extraction, see Fig. 4.4. Extraction with DCM and MeOH
removes hydrophobic and semi-polar substances.
Togola et al. (2008) had problems reducing the uronic acids in connection with the linkage
studies of the polysaccharides from the bark of C. cordifolia. It was shown by IR that the uronic
acids not were esteriﬁed. Since this was the case, the presence of divalent ions like Ca2+ and
Mg2+ may have created ionic cross-linkages of carboxyl groups in chains. Strong ionic cross-
linkages may have hindered the reduction of the uronic acids. An intermediate reaction with
carbodiimide is necessary to convert the uronic acids to lactones, so that the lactones can be
reduced in a second step by sodium borodeuteride (NaBD4) (Kim & Carpita, 1992). Successful
reduction of the pectins from C. cordifolia bark was achieved in Paper I by ﬁrst removing
the divalent ions by passing the extracts through a solid phase chelator, Chelex 100. The cross-
linking of the pectins before removal of divalent ions was visualized by atomic force microscopy
(AFM), see Fig. 4.5 AFM. AFM has previously been used to image individual pectin molecules
and to study their aggregation (Morris et al., 2011).
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Figure 4.5: Atomic force microscopy. Topography images of (left) CC1 before divalent ion
removal (2.0 x 2.0 μm), (right) CC1 after Chelex (1.0 x 1.0 μm).
High viscosity was also observed in the leaf fractions (Paper II). Divalent ions were therefore
removed prior to fractionation, but unfortunately the removal of the divalent ions was not as
efﬁcient as reported for the bark extracts (Paper I) and the extracts therefore remained viscous.
This may be due to a higher initial viscosity of the polymer fractions in addition to the fact
that the extracts were not ﬁrst separated on the ANX-IEC as was done for the bark fraction, but
passed directly through the Chelex column in an earlier stage of fractionation, see Fig. 4.3.
4.2.1 Structures of pectins from the bark of C. cordifolia (Paper I)
The puriﬁed fractions CC1P1 and CC1P2 were analyzed for monosaccharide contents and type
of linkages present using GC and GC-MS (see table 1) as well as analyses by various NMR
techniques. CC2 was analyzed for monosaccharide content and linkage types only.
As seen from the linkage analysis, table 1, CC1P1 consists of T-Gal, 1→2,3 linked Rha and
1→4 linked GalA in the ratio 1:1:1. Due to the simplicity of the structure, it was possible to un-
ambiguously deduce the whole structure by NMR, see Fig. 4.6. A Mw of 135 kDa corresponds
to n= 40 in Fig. 4.6(a).
The spin system for each sugar residue of CC1P1 was assigned according to the COSY spec-
trum, Fig. 4.7, with assistant/conﬁrmative information from the TOCSY (spectra not shown).
The sequence of the linkages of sugar residues was inferred from the HMBC. The anomeric
conﬁguration of the monomers was based on measurements of coupling constants and compar-
ison of the chemical shifts with data from literature (Duus et al., 2000; Bock et al., 1984; Bock
& Thøgersen, 1983). We found that the three monomers had α conﬁguration. Gal is normally
found to be present as β conﬁguration. However, lately, similar types of pectins were found in
ﬂaxseed hulls. The structure had 1→2,3 linked Rha in the RG-I backbone and monomeric ter-
minal αGal (in addition to other monosaccharides) attached to O-3 of Rha ﬂaxseed hulls (Qian
et al., 2012).
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Figure 4.6: (a) Proposed structure of CC1P1. (b) and (c) Hypothetical drawings of the low
energy conform of CC1P1, [2→)[α-D-Gal(1→3)]α-L-Rha(1→4)α-D-GalA(1→]20.
Figure 4.7: COSY spectrum of CC1P1. Abbreviations: The two last letter/numbers indicate the
location of the proton (H). The ﬁrst letter(s) indicates the monosaccharide; G=Gal, GA=GalA,
R=Rha.
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Paper I Paper II
CC1 CC2 LCC50%A LCC100A
P1 P2 P1 P2 P1 P2
Ara Tf 1.6 15.9 7.5 1.6 5 3.8
1→3f 5.7
1→5a 9.6 4.4 1 5.9
1→3,5a 3.3 1.8 1 0
1→2,5a 2.7 2.4 1.2 2.8
Rha Tb 2.7 1 1
1→2 3.2 1 0.7 1 3
1→3 0.3 0.6 0.5 0.4
1→2,3 32 15.3 1.1 9.8 10.2 9 4.4
1→2,4 8.2 1.5 3.7 7.4 1.7 3.3
Xyl T 1.3 0.6
1→4 1.4 0.6
Gal T 31 7.9 3.3 8 7.5 7.2 4.6
1→3 5.2 1.3 2.1 1 1.4
1→4 13 1.8 6 7.1 1.1 3.7
1→6 3.2 1.3 0.4
1→3,6 17.8 3.9 0.9 1.2
2-OMe-Gal Tp 6.7 3.5
4-OMe-GlcA Tp 14.9 6.6 8.2 21.5 2.3 5.1
GalA 1→4 35 23.9 11.5 29 19.5 58.5 50.7
1→3,4 5.7 4 12.7 4 4
1→2,4 1.3 1.6 2 1 1.5
a It is not possible to distinguish between 1→5 linked Araf and 1→4 Arap
b The conformation is pyranose if otherwise not stated.
Table 4.1: Linkage analysis. GC-MS of methylated alditol-acetates of selected pectin frac-
tions from the bark (CC1P1, CC1P2 and CC2) and the leaves (LCC50%A-P1, LCC50%A-P2,
LCC100A-P1 and LCC100A-P2).
The 3JCH HMBC couplings conﬁrmed a RG-I backbone consisting of [→4)αGalA (1→2) αRha(1→].
All terminal α-Gal were linked via O-3 to α-Rha (spectra not shown). This information was
also inferred by the 3D HSQC-NOESY spectrum, see Fig. 4.8. The NOE signals can bee seen
in a distance up to 5Å under the right circumstances. The HSQC-NOESY gave additional infor-
mation about the three-dimensional (3D) structure, as it provides distance constrains between
the protons that are located on average less than 5Å from each other. In general, NOE peaks
with a high intensity are located closer together than the weaker correlations. The two protons
bound to the carbons participating in the glycoside linkage will give medium intensity, as the
protons are situated approximately 2.4Å away from each other, as calculated in Chem BioDraw
ultra 13.0, see correlations marked with green rings in Fig. 4.8. Correlations giving information
about distance constrains in the 3D structure of CC1P1 are marked by blue circles on Fig. 4.8.
The information obtained from the distance constrains is illustrated on Fig. 4.9.
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Figure 4.8: HSQC-NOESY (3D) spectra of the anomeric signals of CC1P1. The red circles
indicate pure HSQC (1JCH correlations), the green circles indicate NOE constrains between the
protons that are located adjacent to the carbons participating in the same glycoside linkage,
blue circles indicate NOE signals giving information about distance restrains closer than 5Å.
Abbreviations: The two last letter/numbers indicate the location of the proton (H) or the carbon
(C). The ﬁrst letter(s) indicates the monosaccharide; G= Gal, GA=GalA, R=Rha.
Figure 4.9: NOE distance constrains found in CC1P1
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Fig. 4.9 shows that GalA is probably tilted more so that H3 of GalA is closer to H1 of Rha.
Rha must also be turned to the left to have a conformation responding to what is seen in the
HSQC-NOESY spectrum. As can be seen from Fig. 4.6 (b), the methyl groups of Rha are facing
directly outwards making the surface more hydrophobic. However, the surface is still negatively
charged due to GalA. SEC-MALLS results indicate that CC1P1 is almost homogeneous with a
PDI (Mw/Mn) of 1.2. The MHS plot (intrinsic viscosity as a function of molar mass) showed that
CC1P1 is rather stiff, comparable to alginate. The stiffness is attributed to the RG-I backbone.
CC1P2, eluting after CC1P1 (MonoP column), had a more complex nature consisting of 15%
4-OMe-GlcA and 6.7% 2-OMe-Gal. We see from the non linear conformation plot obtained by
SEC-MALLS analysis, that CC1P2 was heterogeneous, meaning that it consists of subpopula-
tions with different extensions of side chains. This fraction was also subjected to NMR analysis,
but due to its complexity, we were not able to deduce the whole structure. HMBC was difﬁcult
to record, so the sequence of the linkages of sugar residues was inferred by the HSQC-NOESY
and the NOESY. Rha and GalA were clearly alternating as seen from the inter-residue connec-
tivities of Rha H1 - GalA H4, and GalA H1 - Rha H2. Strong NOEs were observed between
2-OMe-Gal H1 and 1→2,3 linked Rha H3. 2-OMe-Gal is therefore deduced to be linked di-
rectly to the backbone via O-3 of Rha, see Fig. 4.10. Correlations between H1 of 1→2,3 linked
Rha and H1 of 4-OMe-GlcA might indicate that 4-OMe-GlcA is not directly linked to Rha,
but to the adjacent GalA in the RG-I backbone. We identiﬁed three different spin systems for
1→2,3 linked Rha. This indicates that 1→2,3 linked Rha is present in three different electronic
surroundings, presumably meaning that the unit is attached to different monomers. We could
not unambiguously ﬁnd all the three Rha and connect them to neighboring subunits. However,
the Rha spin system found to have correlations with H1 of 2-OMe-Gal, also have correlation
with 4-OMe-GlcA. This indicates that 2-OMe-Gal and 4-OMe-GlcA are probably linked to ad-
jacent monomers, Rha and Gal A respectively. Capek et al. (1987) and Renard et al. (1999)
have previously found terminal GlcA directly linked to O-3 of 1→3,4 linked GalA in the RG-I
backbone. This supports our theory that Rha and GalA have both O-3 linked side chains, where
4-OMe-GlcA is linked to GalA. However, it is more 4-OMe-GlcA (14.9%) present than 1→3,4
linked GalA (6%) which indicates that T-4-OMe-GlcA also has to be present linked to an other
monosaccharide. This unit is probably not Rha as we did not see any correlations between these
units. H1 of Gal1→4 shows correlations with Rha H3. Therefore, it is possible that T-4-OMe-
GlcA may be linked to 1→4 Gal. Due to a crowded spectrum in the 4 ppm region, we did not
succeed to determine correlations between 4-OMe-GlcA and Gal.
We could not detect correlations between H1 and H4 of GalA, suggesting that homogalactur-
onan (HG) was not present. NMR is not a very sensitive method, so we cannot exclude small
amounts of HG. A tentative suggestion of the overall structure of CC1P2 can be found in Fig.
4.10. How the monomers, as found linked together by NMR, are distributed on the RG-I back-
bone is difﬁcult to deduce. They can be randomly distributed along the RG-I chain, they can be
found in blocks and some elements can even be present in different populations of the polymers
as seen by SEC-MALLS.
In order to determine the structure in more detail, selective degradation, separation and analy-
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Figure 4.10: Hypothetical drawings of CC1P2 based on linkage analysis (GC and GC-MS) and
NMR. One monomer on the ﬁgure correlates to a content of 2% in the fraction.
ses of the oligomers obtained can reveal more about the true structure. It was tried to degrade
CC1P2 with rhamnogalacturonase without success. These enzymes are often difﬁcult to pu-
rify and unfortunately not possible to buy. Chemical β-degradation of the RG-I backbone can
be an alternative. However, adding an electron withdrawing group on the carboxylic acid of
GalA, enabling β-degradation (i.e. trans elimination of the glycoside binding on C4 of GalA),
was shown to be difﬁcult because conventional methods for methyl esteriﬁcation of carboxylic
groups use DMSO as solvent (Deng et al., 2006). Unfortunately, CC1P2 did not dissolve well
enough in DMSO for esteriﬁcation of the carboxylic groups. Production of an intermolecular
lactone between hydroxyl (OH) at C4 and the carboxylic acid of GalA with carbodiimide was
therefore tried. This resulted in clear degradation of the molecule, providing a reduction in Mw
from 1400 kDa to approximately 90 kDa (unpublished results from SEC-MALLS). Surpris-
ingly, analysis on a Bio-LC (HPAEC-EC) gave results which were difﬁcult to be reproduced
Fig. 4.11.
CC2 is structurally not related to CC1P1 and CC1P2. CC2 contains a high degree of arabinans
and AG-II side chains, see Fig.4.12, and therefore resembles pectin structures commonly found
in medicinal plants (Paulsen & Barsett, 2005). SEC-MALLS showed a compact, but ﬂexible
nature due to the long side chains. The MW was determined to be 63 kDa, corresponding to
approximately 350 monomers, or the structure in Fig. 4.12 repeated approximately seven times.
The AG-II side chains were heavily branched with 17.8% 1→3,6 Gal. Normally, terminal
monosaccharides of AG-II are Ara or Gal, but GlcA and 4-OMe-GlcA residues can also be
present (Mohnen, 2008). Presence of GlcA and 4-OMe-GlcA as terminal units on the surface
of the AG-II side chains of CC2 is highly likely. Due to large branches and a relatively low
amount of GalA (11.5%), the viscosity of CC2 was low. The protein content of CC2 was 1.3 %
±0.2% (unpublished results), and CC2 is therefore probably not an arabinogalactan protein.
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Figure 4.11: HPAEC-EC proﬁle from β-elimination of CC1P2.
Figure 4.12: A hypothetical structure of CC2 based on linkage analysis and methanolysis. One
monomer on the ﬁgure correlates to a content of 2% in the fraction.
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Figure 4.13: A hypothetical structure of LCC50A-P2 based on linkage analysis (GC and GC-
MS).One monomer on the ﬁgure correlates to a content of 2% in the fraction.
4.2.2 Structures of pectins from the bark of C. cordifolia (Paper II)
The water extract from the leaves was fractionated according to Fig 4.3.Isolating pectin fractions
from the leaves proved to be more challenging than purifying bark fractions. The viscosity was
higher and the fractions were more polydisperse and also more heterogeneous. Compared to
the bark, the leaves are constantly renewed and they are therefore also in a more dynamic state
of development when it comes to pectin synthesis and remodeling. Pectins have a direct role
in cell wall rheology and stoma functions, and they work as plasticizer in regulation of Ca2+
mediated interactions of HG (Harholt et al., 2010). Considering that the bark and leaves have
different biological functions in the two plant parts, it is not surprising that the pectins present in
leaves are structurally dissimilar, even though the pectins origin from the same genetic material.
Deduced from the linkage analysis, arabinan side chains are present in LCC50%A-P1, LCC100A-
P1 and LCC100A-P2 as seen from the presence of terminal Ara, in addition to 1→5, 1→3,5 and
1→2,5 linked Ara (Table1). In addition to arabinan side chains, LCC50%A-P1 contains AG-II
as shown by the presence of 1→3,6 Gal, 1→3Gal, 1→6Gal and terminal Araf in addition to a
positive Yariv precipitation.
As calculated from SEC-RI results (Paper II), LCC50%A-P1 and LCC100A-P1 contained ap-
proximately 25% and 15% free oligosaccharides respectively. The HPAEC-EC chromatogram
from the oligosaccharides with a size of less than 3kDa isolated of LCC50%A-P1 and LCC100A-
P1 showed a presence of three overlapping peaks. Methanolysis of LCC50%A-P1 <3 kDa
showed a presence of 22% Ara, 9.8% Rha, 9.8% Xyl, 5.8% Gal, 6.4% 4-OMe-GlcA, 34.7%
GalA and 11.5% Glc. Linkage analysis was not carried out. As the mother fraction LCC50%A-
P1 (>3kDa) were depleted from Xyl after removal of oligosaccharides, we conclude that Xyl
was not present as part of xylogalacturonans, and only present as oligomers (see 4.1).
LCC100A-P2 was analyzed by NMR. Due to heterogeneity, high viscosity and presence of
complex arabinans the spectra gave poor resolution. This fraction was therefore not suitable for
NMR analysis.
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4.2.3 Comparing pectins from bark and leaves of C. cordifolia (Paper I
and II)
The pectic fractions derived from C. cordifolia diverge structurally from pectins commonly
found in medicinal plants from Mali (Grønhaug et al., 2010, 2011; Inngjerdingen et al., 2007;
Nergaard et al., 2005c; Diallo et al., 2001). Generally, the pectins present in the bark and
leaf of C. cordifolia differ from these by having RG-I backbone with the rather uncommon
1→2,3 linked Rha instead of the more common 1→2,4 linked Rha. In addition,they have a
high frequency of short side chains consisting of the monomers T-4-OMe-GlcA, T-Gal or T-2-
OMe-Gal. Infrared spectroscopy (IR) analysis did not show any absorption in the relevant areas
corresponding to esters for bark and leaf polysaccharide fractions, thus the free uronic acids are
responsible for the resulting cross-linkages present caused by divalent ions.
The leaf fractions had a higher content of HG compared to bark fractions and also a higher
viscosity. However, pectins from both plant parts have a higher viscosity than what should
be expected. A reason for this may be that the short monomeric side chains cannot provide
steric hindering of the HG cross-linking. In addition, the 4-OMe-GlcA terminal units may also
participate in crosslinking with divalent ions. Pectins from the vegetable okra or lady’s ﬁngers
(Abelmoschus esculentus) are similar in structure compared to pectins found in C. cordifolia.
The vegetable is well known for the high viscosity of the fruit juice.
Despite the general similarities between the pectins present in the bark and leaves, it was not
possible to follow the same fractionation scheme for polysaccharides from the two plant parts.
The leaf polysaccharide fractions LCC100-I and LCC50%-I, that should correspond to the main
bark fraction CC1, diverged from CC1 in addition to precipitate in solution. It was therefore not
possible to follow the same fractionation scheme which makes it difﬁcult to directly compare
fractions.
The most puriﬁed fractions from the bark were generally more homogeneous and less polydis-
perse compared to those from the leaves. In addition, free oligosaccharides were not present in
the bark. These differences can be due to the fact that the leaves are in constant construction,
while the bark is more in a steady-state concerning biosynthesis of pectins.
The leaf fraction LCC50%A-P2 was structurally similar to CC1P2. However, they differ in
the amount of 2-OMe-Gal, which seems to be more abundant in CC1P2, and of 4-OMe-GlcA,
which is present in higher amounts in LCC50%A-P2. In addition, branching on GalA is more
abundant in LCC50%A-P2, which might be related to the presence of 4-OMe-GlcA (as this unit
is probably linked to O-3 on GalA). The AG-II rich fraction CC2, present as one of the main
fractions in the bark, was not found i the leaves.
In Paper III de-fatted plant material from bark and leaves are extracted with 50°C water to
produce the extracts CCbark50 and CCleaf50 (see Fig. 4.4). The monosaccharide compositions
determined by GC showed similarities between the two polymers, but CCbark50 contained
more 2-OMe-Gal, 4-OMe-GlcA, Rha and less GalA. The higher amounts of GalA, in addition
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to lower amounts of Rha in the leaf polysaccharide, suggest a presence of less RG-I and more
HG. The presence of HG, which can participate in cross-linkages with divalent ions, may be the
reason for why the polysaccharide CCleaf50 had a much higher viscosity than CCbark50.
The phenol-content of CCbark50 and CCleaf50 was evaluated since phenolic substances can
interfere with immunological assays. A high phenolic content can often indicate presence of
tannins. Tannins are incompatible with many of the ingredients in the in-vitro assays, i.e. with
metal salts and proteins. The leaves showed 10 times higher phenolic content compared to the
bark (18.8 and 2.2% respectively).
4.3 Immunomodulating properties and structural requirements
Polysaccharides capable of interacting with the immune system by up- or down-regulating spe-
ciﬁc aspects of the host response can be classiﬁed as immune modulators. Polysaccharides like
pectins and β-glucans have been reported to display a variety of immune modulating activities
(Schepetkin & Quinn, 2006; Goodridge et al., 2009; Yamada & Kiyohara, 2007). More detailed
information about immunomodulating activity is found in §1.2. The puriﬁed pectins from the
bark and leaf of C. cordifolia (Paper I and II) were investigated and tested for immune modula-
tion by complement ﬁxation and macrophage stimulation, see Fig. 4.14. The polysaccharides
CCbark50 and CCleaf50 (Paper III) were tested for complement ﬁxation abilities only.
4.3.1 Complement ﬁxation activity
CC1P1 from bark (1:1:1 ratio of Rha:GalA:Gal), shows the highest complement activating ac-
tivity of all polysaccharide fractions tested. Previously, it was suggested that the hairy regions of
RG-I, with complex galactans or AG-II side chains attached, are important for activity (Paulsen
& Barsett, 2005; Yamada & Kiyohara, 2007). CC1P1 has only T-Gal attached to the RG-I
backbone, but still shows a fairly high activity (three times more active than PMII). This means
that complex galactans are not an absolute requirement as monomeric side chains of T-Gal also
shows activity.
CC1P2 has a high frequency of short side chains, see Fig. 4.10. However, the terminal groups
consisting of acidic 4-OMe-GlcA make the surface negatively, and this seems to reduce the
complement ﬁxing activity compared to CC1P1.
In theory, CC2 has the structural requirements important for exhibiting a very high activity in
the complement system. However, as also seen for CC1P2, we believe that the negative charged
terminal groups reduce the activity. Looking at the tentative structure, see Fig. 4.12, the Gal
units are covered by acidic sugars like 4-OMe-GlcA and GlcA, which gives the side chains an
acidic surface. This is in agreement with what suggested by Yamada & Kiyohara (1999) that
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Figure 4.14: Complement ﬁxation. The bars show ICH50-PMII divided on ICH50-sample and
thus shows how active each individual test sample is compared to the positive control, PMII.
These results are based on three separate experiments. **p<0.01, *p<0.05 compared to PMII.
Brown bars represent bark fractions, green bars represent leaf fractions.
high complement ﬁxing activity seen for pectins is due to neutral side chains attached to the
RG-I backbone. The AG-II side chains of CC2 are not neutral and will therefore probably be
less active than the corresponding neutral AG-II side chains.
LCC50%A-P2, see tentative structure in Fig. 4.13, has a highly branched structure with mono
or disaccharides attached to the RG-I backbone, and is structurally similar to CC1P2. However,
LCC50%A-P2 contains even higher amounts of negatively charged uronic acids facing the sur-
face compared to CC1P2. The complement ﬁxing activity is lower for LCC50%A-P2 compared
to CC1P2, which is in agreement with our theory that a negative surface down regulates the ac-
tivity. In addition, LCC50%A-P2 contains HG which have been shown to reduce the activity
(Yamada & Kiyohara, 2007). LCC50%A-P1 has a higher activity compared to LCC50%A-P2
(p<0.05). This may be due to the presence of AG-II structures and arabinans in LCC50%A-
P1, which can increase the activity and a lower amounts of acidic monosaccharides in terminal
positions. The activity of the oligosaccharides present in LCC50%A-P1 shows no activity in
the complement assay. LCC50%A-P1>3 kDa has not been tested, but the activity is probably
higher than what reported for LCC50%A-P1.
CCbark50 and CCleaf50 (Paper III) were also evaluated in the complement ﬁxation assay. In-
terestingly, CCleaf50 did not show any activity, see Fig. 4.15, while the ICH50 of CCbark50
was 50 μg/ml. We attribute the low activity of CCleaf50 to interference of polyphenols which
were present at a concentration of 18.8%. BPII was used as a positive control instead of PMII
used in Paper I and II. PMII normally have an ICH50 value of 70 μg/ml (Paper I), which makes
CCbark50 equal or more active compared to PMII.
LPS is shown to activate the complement through the alternative pathway, but since we use a
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Figure 4.15: Complement ﬁxation. Concentration dependent activity of (left) CCbark50 (◦) and
CCleaf50 (♦); (right) inﬂuence of LPS on the inhibition of hemolysis. BPII (), BPII added
LPS (10 μg/ml) (∗) and pure LPS (). BPII from B. petersianum () was used as a positive
control.
1:70 dilution of human serum (the source of complement) (Michaelsen et al., 2000) the alter-
native pathway will be inactive. Our results see Fig. 4.15, show that interference with LPS is
practically non-existing and removal of LPS prior complement ﬁxation is therefore unnecessary
when using Method A (Michaelsen et al., 2000).
4.3.2 Macrophage induction
CC1P1 did not induce macrophage activity, while 10 μg/ml of CC1P2 induced nitric oxide
release in comparable amounts to that of LPS 0.5 μg/ml, see Fig. 4.16. Apparently, the short
side chains of single Gal monomers in CC1P1 are not sufﬁcient for stimulation. However,
CC1P2 also have short side chains, but the activity is high. This may be due to the presence
of negatively charged terminal 4-OMe-GlcA. Inngjerdingen et al. (2008) suggested that the
presence of arabinogalactan side chains is part of the structural requirements for the induction
of macrophage response.
LPS was not removed from CC1P2 prior to macrophage co-incubation. However, we ﬁnd it
unlikely that the observed activity is due to presence of LPS contamination since CC1P1 did
not induce macrophage activation. CC1P1 and CC1P2 are obtained in the same fractiona-
tion step, which normally should result in the same contamination rate of LPS. All leaf frac-
tions, LCC50%A-P1, LCC50%A-P2, LCC100A-P1 and LCC100A-P2 were passed through a
Detoxy-Gel™column (polymyxin B). We could not detect any macrophage stimulation of any
of these fractions. Detoxy-Gel™is not recommended for LPS removal from pectins, because
insufﬁcient LPS removal from pectins has been observed (personal communication Samuelsen,
34
Figure 4.16: Stimulation of macrophages with extracts from C. cordifolia bark. NO(g) liberated
from activated macrophages is naturally broken down to nitritte which is measured by colori-
metric detection. A representative result is given as mean ±SD. LPS and PMII are present as
positive controls.
A.B.). However, as none of the fractions showed any activity, LPS was not present in interfering
amounts.
4.4 Anti-ulcer activity of polysaccharide rich extracts from
V. kotschyana and C. cordifolia (Paper III and IV)
Since gastric ulcer is regarded as an important public health problem in Mali, DMT wanted
to focus on the traditional use of C. cordifolia as an anti-ulcer medicine. Polysaccharide rich
extracts from C. cordifolia bark and leaves, see Fig. 4.4, (Paper III) were therefore tested for
anti-ulcer activity in a preliminary acute experimental rodent model. The polysaccharide rich
fractions CCbark50 and CCleaf50 showed a similar and dose dependent inhibition of ulcer for-
mation (50 and 200mg/kg). The HCl/EtOH induced ulcer model is commonly used for screen-
ing of anti-ulcer activity of herbal drugs. Mechanisms that have been proposed for anti-ulcer
activity of pectins include mucosal protective coating, anti-secretory activity of gastric acid
and pepsin in addition to radical scavenging activity (Matsumoto et al., 2002). Karaya gums
(E-417) isolated from Sterculia species from the same family as C. cordifolia, Malvaceae, con-
tains pectins with similar carbohydrate composition (Singh & Chauhan, 2011). Cross-linking
of karaya gums with divalent ions was found to create structures that delay stomach empty-
ing (Singh & Chauhan, 2011; Singh et al., 2010). Residual pectins in the stomach when the
necrotizing agent is administered may physically hinder the creation of lesions by coating the
epithelial cells or diluting the necrotizing agent. Delay of stomach emptying could therefore
also be a possible anti-ulcer mechanism of C. cordifolia pectins.
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The acute anti-ulcer rodent model is probably not the best model for studying anti-ulcer activ-
ity as chronic H. pylori infection is the main factor for developing gastric ulcer. A standard-
ized mouse model of H. pylori infection (Lee et al., 1997) could probably be a better screen-
ing method. However, H. pylori anti-adhesion studies of fractions from the leaves and bark
(LCC100A and CC1 respectively, Paper II) showed no signiﬁcant activity, and direct antibac-
terial activity is unlikely since anti-microbial activity of pectins has not been reported before.
The traditional use as an anti-ulcer medicine is therefore probably not explained by a direct
activity on H. pylori colonization, and an immunomodulating activity is more likely. In the-
ory, H. pylori anti-adhesive herbal drugs can only be used prophylactic, as a dissociation of the
bacteria already in the state of adherence with the host tissue seems highly unlikely (Wittschier
et al., 2007). Anti-adhesive traditional medicines would therefore have to be used for lifetime,
starting at a young age. The fact that most people in Mali are already infected with H.pylori,
anti-adhesion is probably not a functional mechanism.
Roots of V. kotschyana are well known for anti-ulcer activity (more detailed information about
the use is found in the introduction; subsection Vernonia kotschyana). Previously, saponins
were claimed to be the active components responsible for the anti-ulcer activity observed of the
roots (Germano et al., 1996; Sanogo et al., 1996). We wanted to examine if the polysaccharides
also may be an active component contributing to the anti-ulcer activity (Paper IV). 50°C and
100°C water extracts named VK50-I and Vk100-I (see Fig. 4.4) were highly active at a dose
of 100 mg/kg, corresponding to the recommended daily dose of root powder of 15 g per person
(Germano et al., 1996). We therefore concluded that inulin also contribute to the activity in
the acute experimental ulcer model. However, whether or not this assay is relevant for chronic
ulcer in humans remains in our opinion, controversial. A mechanism for anti-ulcer activity of
inulin which is not evaluated in this model, is the biﬁdogenic activity of inulin. This activity
might contribute to a better microbial ﬂora in the intestine which again will provide relief of
dyspeptic symptoms. The amount of soluble dietary ﬁber intake in Mali through fruits and
vegetables are low (Hall et al., 2009), which may explain why inulin supplements can relieve
the symptoms. Pectins from C. cordifolia will probably not work as prebiotics since studies on
prebiotic-function of the structurally related karaya gum showed that the gum was not degraded
by a variety of intestinal bacteria (Salyers et al., 1977). However, it can act as a mechanical
laxative.
Through interviews with 59 randomly selected persons in the Bamako region (Paper V), we
observed that the majority (61%) experienced gastrointestinal symptoms. This reﬂects the high
degree of gastrointestinal related ailments in the population of Mali. Natural products lowering
the dyspeptic symptoms, may be highly relevant for further research because rapid recurrence
and antibiotic resistance are increasing problems in countries with a high prevalence of H. pylori
(Ahuja & Sharma, 2002). Also, since Mali is ranked as one of the poorest countries in the world,
medicinal plants are the main option for most of the primary health care of the population. It
is therefore highly important to carry out more research on traditional medicines used for these
types of ailments.
36
4.5 Gastric ailments and diagnosing H. pylori (Paper V)
Gastrointestinal ailments are major reasons for morbidity in Mali. The prevalence of gastric
ulcer in the population is reported to be 4.2% for men and 2.4% for women, and is probably
higher for gastritis (Touré, 1989; Maïga et al., 1995). Since H. pylori is recognized as the major
risk factor for developing gastritis and gastric ulcer, diagnosing H. pylori in a none-invasive
manner can be a valuable diagnostic tool. Rapid tests for H. pylori detection are important tools
for future plans on clinical studies on gastric ulcer and traditional medicine. For this reason,
Paper V focuses on rapid tests for H. pylori diagnosis.
To evaluate Clearview® immunochromatographic rapid tests, we used whole blood from pa-
tients with conﬁrmed gastric ulcer by gastroscopy. 21% (conﬁdence level 95%: 6;35) of the
patients were positive based on the rapid test. This number is presumable too low as patients
with conﬁrmed gastric ulcer normally have a H. pylori prevalence of 60-100% (Kuipers et al.,
1995). Previously, a study carried out in Mali by Mourtala (2000) found that H. pylori was
present in 95% of the gastric ulcer lesions. The detection techniques used were biopsy and
histology. Based on this, we concluded that the serological test Clearview® cannot be used in
Mali. We therefore tested a stool based rapid test (ImmunoCard STAT! antigen test) on patients
suffering from unknown gastric ailments. Only 14% tested positive on H. pylori, a result which
is unlikely to be true as research in neighboring countries has revealed a prevalence of more
than 80% (diagnosed by biopsy) in patients with dyspepsia.
According to the manufacturer of the stool test, it is a possibility that the stool test does not
respond to all subgroups of H. pylori as there is a remarkable genetic diversity (Varbanova
et al., 2011). In addition, anti-malarial drugs may lower the amount of H. pylori present in the
stomach, which again will result in lower amounts of antigens in the faces (stool). We therefore
conclude that Clearview®hp and ImmunoCard STAT!hp rapid tests should not be used in Mali.
4.6 Conclusions
According to WHO, 75% of the Malian population depends on traditional medicines. Gastric
ulcers and wounds are major health problems in Mali, and this thesis focuses on two plants used
for these ailments, C. cordifolia and V. kotschyana. Traditional plant medicines are normally
prepared as a decoction, extracting water soluble components. Polysaccharides are highly sol-
uble in hot water and will therefore also be present in the prepared medicines. The fact that
polysaccharides often express immunomodulating activities make them likely to be parts of the
claimed activities of a medicinal plant, especially when it comes to healing of gastric ulcers and
wounds. The polysaccharides can be the working components of the plant medicines, alone
or in synergies with water soluble low molecular weight substances like saponins, ﬂavonoids,
alkaloids and terpenes.
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In this thesis, a detailed study of pectin structures found in C. cordifolia bark and leaves were re-
lated to complement ﬁxation, macrophage activation and anti-ulcer activity. Uncommon pectin
structures with RG-I backbone having a high degree of branches O-3 linked to Rha and GalA
with mono or dimeric side-chains consisting of a high degree of 4-OMe-GlcA, will give a
highly negative surface for a majority of the fractions. Pectins isolated from the bark and leaves
showed similarities in the structure. However, some differences in the amount of T-2-OMe-
Gal and 4-OMe-GlcA, and HG proved to be important for immunomodulating activities and
physiochemical properties. The bark fractions had generally higher complement ﬁxing activity,
in addition to a higher potential of activating macrophages. The observed difference in activ-
ity may be due to these relatively small structure differences, but cross-linking of HG blocs in
pectins from leaves may be an indirect parameter for altered activity. CCbark50 and CCleaf50
showed similar anti-ulcer activity in an experimental mouse model in a dose dependent way.
50°C and 100°C water extracts from the roots of V. kotschyana (high content of inulin) were
also subjected to anti-ulcer experiments and the extracts showed a high anti-ulcer activity with
doses corresponding to the recommended daily intake of the root.
H. pylori is regarded as the main factor for dyspepsia, gastritis and gastric ulcer development.
The next step in evaluating the anti-ulcer activity of medicinal plants used for ulcer treatment
will be to carry out new clinical trails. Simple rapid-tests were evaluated for H. pylori diagnosis.
Unfortunately, the tests showed low sensitivities in the Malian population, probably due to strain
variability and use of anti-malarial drugs.
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Abstract 
 
Background  
Gastrointestinal diseases are major reasons for morbidity in Mali. As Helicobacter pylori is 
known to play a major role in gastritis and gastric ulcer we wanted to find a simple method 
for detection. 
 
Methods  
Twenty-nine volunteers with confirmed gastric ulcer by gastroscopy and 59 randomly 
selected volunteers were diagnosed by using the rapid serological test Clearview® H. pylori. 
The ImmunoCard STAT!® HpSA® test was applied on stool from 65 volunteers seeking 
help for gastrointestinal related ailments.  
 
Results 
A Helicobacter pylori prevalence of 21% was found among the individuals with confirmed 
gastric ulcer, 44% among the randomly selected volunteers and 14% in individuals with 
gastrointestinal related ailments.  
 
Conclusions 
According to what is already known about the aetiology of gastric ailments and the 
prevalence of Helicobacter pylori in neighboring countries, the infection rates in our study 
appear strikingly low. This might indicate that Clearview® H. pylori and ImmunoCard 
STAT!® HpSA® have low sensitivities in the populations studied. Strain variability of H. 
pylori may be an explanation. The tests need to be properly evaluated in Mali before they can 
be relied upon as diagnostic tools.  
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Introduction 
Gastritis and other gastrointestinal (GI) disorders are important causes of morbidity in the 
African population [1]. In Mali, the prevalence of gastric ulcer in the population is reported to 
be 4.2% for men and 2.4% for women, and is probably higher for gastritis and non-ulcer 
dyspepsia [2, 3]. Medicinal plants are popular remedies for treating gastrointestinal ailments 
in Mali, as approximately 75% of the population mainly use plant based medicines for their 
primary health care [2, 4, 5]. It is important to increase the knowledge behind the aetiology of 
gastritis, gastric ulcer and GI-related problems in Mali for future research on Malian 
traditional medicines used for these ailments, and also in order to give patients the correct 
treatment.The presence of Helicobacter pylori in the population is one important factor 
needing assessment, as H. pylori is a known factor contributing to dysfunction of the GI.  
 
Individuals may be asymptomatic carriers of the disease, but the presence of H. pylori is 
highly correlated with underlying ailments causing dyspepsia. Infections with H. pylori are 
found worldwide in individuals of all ages, but are commonly acquired at an earlier age in 
developing countries [6]. A previous study conducted in Mali on patients with gastric ulcer 
reported an H. pylori prevalence of 95% [7]. The prevalence of H. pylori in dyspeptic patients 
in other West African countries, diagnosed by biopsy and urease test, is reported to be 97% in 
Ghana [8], 91.3% in Ivory Coast [9], and 72-91% in Nigeria [10, 11]. In Senegal a prevalence 
of 100% was found in patients with ulcers or gastritis by urea breath test and histological 
findings [12].  
 
Rapid stool- or serology-based chromatographic immunoassays were chosen in this study, as 
we wanted to diagnose patients in Mali with a simple, non-invasive technique.  
 
Methods and material 
Volunteers with confirmed gastric ulcer 
Twenty-nine volunteers diagnosed with gastric ulcer, 18 (62%) male and 11 (38%) female, 
confirmed by gastroscopy at Cabinet Medical "Les étoiles" at Gabriel Touré hospital, 
Bamako, were tested by the chromatographic immune based assay Clearview® H. pylori 
(Alere Inc., Waltham, MA). Nine different ethnic groups were included; Bambara (31%), 
Peulh (28%), Sénoufo, Malinké, Somono, Dogon, Dafing, Sonrhaï and Minianka. The 
average age was 41 years (age 27 – 65 years). H. pylori antibodies (IgG) present in fresh 
whole blood were analysed according to the manufacturer’s instructions. Briefly, a thin lancet 
was used to puncture the skin of the finger and 50 μl whole blood and one drop of buffer was 
dispensed into the round window of the test device. The assay was carried out at room 
temperature (30°C), and was read after 10 minutes. A pink-red line, even very weak, was 
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considered as a positive result. All volunteers gave informed consent, confirmed by a 
signature.  
Randomly selected volunteers 
The chromatographic immune based assay Clearview® H. pylori was used to detect H. pylori 
antibodies (IgG) present in fresh whole blood of 59 volunteers. The volunteers were 
randomly recruited from three different areas of Bamako, Mali; Hippodrome, Daoudabougou 
and Sotuba. The group included 31 (53%) female and 28 (47%) male with an average age of 
36 years (age 18 - 65 years). Fourteen different ethnic groups were involved; Bambara (24%), 
Malinké (14%), Bozo, Dafing, Haoussa, Kakolo, Peulh, Sarakolé, Sénoufo, Sonrhaï, 
Tamasheq, Fofana, Sangare and Minianka. Whole blood was analysed as described under 
subsection 2.1. All volunteers gave informed consent, confirmed by a signature or a 
fingerprint.  
Volunteers with diverse gastric ailments 
The chromatographic immune based assay ImmunoCard STAT!® HpSA® Stool antigen test 
(Meridian Bioscience Inc., Cincinnati, OH) was used to detect H. pylori antigens present in 
the stool of 65 volunteers. The stool samples were given at the INRSP (Institut National de 
Recherche en Santé Publique, Bamako) due to ailments like infections (33%), dyspepsia 
(16%) and other stomach related ailments. The group included 33 (52%) female and 31 
(48%) male, and with an average age of 33 years (age 2 – 70 years). Thirteen different ethnic 
groups were included; Sarakolé (23%), Peulh (20%), Bambara (19%), Sénoufo, Dogon, 
Malinké, Kasonké, Kakolo, Maure, Minianka, Diawando, Sonhraï and Somono. All stool 
samples had a pasty consistency and they were analysed at room temperature (25°C) two 
hours after stool sampling, according to the manufacturer’s guidelines. Briefly, four drops of 
diluted stool were dispensed into the round window of the test device and the result was read 
after five minutes of incubation at room temperature. The appearance of a pink-red band in 
the reading window, even very weak, was considered as a positive result. All volunteers gave 
an informed consent for bacteriological research on stool samples.  
Results  
Volunteers with confirmed gastric ulcer 
H. pylori antibodies were detected in 21% of the 29 volunteers diagnosed with gastric ulcer 
by gastroscopy (Table 1). These individuals were tested directly after endoscopy, and had not 
been through H. pylori eradicating regime. No association with a positive detection of H. 
pylori and gender, age or ethnic group was found (Appendix A). 
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Randomly selected volunteers 
H. pylori antibodies were detected in 44% of the randomly selected volunteers (Table 1). No 
association between H. pylori positive individuals, gender, age or ethnic group was found. 
Nine (15.2%) individuals reported that they had previously undergone gastroscopy; out of 
these two were H. pylori positive in the present study. Thirty-six (61%) of the volunteers 
reported that they from time to time experienced dyspepsia, mostly due to Gastroesophageal 
Reflux Disease (GARD), and of these individuals 36% were H. pylori positive. Among the 
volunteers who did not experience GI symptoms, 54% were H. pylori positive. Four of the 
volunteers knew that they had recently been taking antibiotics, and of these three were H. 
pylori positive. See Appendix B for additional data on gender, age, ethnicity and GI related 
problems. 
Volunteers with diverse gastric ailments 
H. pylori antigens were present in 14% of the volunteers suffering from diverse gastric 
ailments (Table 1). Of the nine individuals that were H. pylori positive, five were tested for 
gastrointestinal infections problems. None of the dyspeptic individuals tested positive 
(Appendix C).  
 
 
Table 1: Results obtained from serological and stool based tests in Helicobacter pylori 
detection. 
 Positive   (%) 95% CI n 
Confirmed gastric ulcer 
(serology based) 
21 (6;35) 29 
Randomly selected 
volunteers (serology 
based) 
44 (31;57) 59 
Gastric ailments (stool 
based) 
14 (5;22) 65 
95% CI; 95% Confidence interval, n; No of volunteers.  
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Table 2: Test sensitivities of the utilized serological and stool based tests as given by the 
manufacturer. 
  Test sensitivity 95% CIa 
Clearview® (serology 
based) 
93.0 (87.1;96.7) 
ImmunoCard STAT!® 
HpSA® (stool based) 
96.1 (86.5;99.5) 
95% CI; 95% Confidence interval.  
 
 
 
Discussion 
According to the manufacturer, Clearview® H. pylori is regarded as a sensitive test (Table 2), 
and a negative result should therefore indicate that the person truly is negative. In the present 
study we found that only 21% of the individuals with confirmed gastric ulcer tested positive 
for H. pylori by using Clearview® H. pylori. This number is probably too low to be realistic 
as it does not correlate with a previous investigation carried out in Mali in year 2000. 
Biopsies taken from 121 patients diagnosed with gastric ulcer by endoscopy confirmed that 
H. pylori were present in 95% of the cases [7].The population studied came from the same 
area (Bamako) and the gastric ulcer was diagnosed by endoscopy in the same manner as in 
the present study. The culture and habits have not changed much in Mali the last decade, 
which means that the populations studied should be comparable. It would therefore be 
expected that most of the individuals diagnosed with gastric ulcer in the current study should 
be H. pylori positive.  
 
A low (41%) prevalence was also shown by Clearview® H. pylori among the randomly 
selected volunteers. The H. pylori sero-prevalence of healthy individuals in nearby countries 
is reported to be much higher, 80 – 85% in Nigeria [13] and 75.4% in Benin [14]. In addition, 
random studies in Africa have shown a seroprevalence of 80% [1]. Factors that seem to play 
a role in the infection rate are low-quality drinking water, lack of basic hygiene, habit of 
eating from the same plate as well as poor diet and overcrowding [11, 15].These factors are 
similar between Mali and the surrounding countries, making a comparable prevalence highly 
likely. To our comprehension, the most obvious reason to explain the low detection of H. 
pylori is that Clearview® H. pylori has a low sensitivity in the population studied in Mali. 
Sensitivity is not an intrinsic property of an assay [16], and it is therefore possible that the 
sensitivity experienced in the population studied here, is not the same as for the population 
studied by the manufacturer.  
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A low prevalence of H. pylori (14%) was also found by the ImmunoCard STAT!® HpSA® 
stool test. A good practice in diagnosing H. pylori with antigen tests is that antibiotics should 
be stopped at least four weeks and anti-secretory therapy at least two weeks before testing, as 
these medications negatively affects the sensitivity [11]. In Mali malaria is endemic, and anti-
malaria drugs might have a negative effect on the sensitivity of the test, as these drugs might 
eradicate or decrease the presence of H. pylori [17, 18]. Most of the individuals in our study 
have a low educational level, and it was therefore difficult to know if they had been taking 
any interfering medications. H. pylori is, however, not easily eradicated [19], and self-
medication is probably not sufficient for total removal of the bacteria, but potentially enough 
to lower the amount of stool antigens to make the outcome negative.  
 
According to Meridian Bioscience, it is a possibility that the stool test does not respond to all 
subgroups of H. pylori. There is a remarkable genetic diversity of H. pylori worldwide, the 
number of genetic variability of H. pylori exceeding 2 to 5-fold the variability of other 
bacterial pathogens. Substantial diversity has recently also been described for the important 
virulence factor cagA [20]. This means that ImmunoCard STAT!® HpSA®, which uses 
monoclonal antibodies for detection, might have a lower sensitivity towards antigens 
produced by some strains. Calvet et al. [21] reported a sensitivity of 69-74% for ImmunoCard 
STAT!® HpSA® on patients with dyspeptic symptoms. This is much lower then what 
reported by the manufacturer (Table 2).  
 
A weakness in the present study might be that the serological and the stool tests were not 
carried out on the same individuals, thereby making it difficult to compare these methods 
directly. However, our results suggest that both assays have a considerably lower sensitivity 
in Mali than reported by the manufacturers. A follow-up study is needed in order to give any 
definite conclusions.  
It is noteworthy that the majority (61%) of the randomly selected volunteers experienced 
gastrointestinal symptoms. This reflects the high degree of GI related ailments experienced 
by the population of Mali. Natural products which reduce the density of H. pylori 
colonization and mucus adherence [22], and thereby lower the dyspeptic symptoms, might be 
highly relevant for further research as rapid recurrence and antibiotic resistance are increasing 
problems in countries with high a prevalence of H. pylori [23]. In addition, as Mali is ranked 
as one of the poorest countries in the world, the population has medicinal plants as the main 
option for most of primary health care. It is therefore highly important to carry out more 
research on traditional medicines used for these types of ailments, and also to have access to 
simple and non-expensive diagnostically methods reliable for the Malian population.  
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Conclusion:  
Rapid immunoassays for H. pylori detection need to be properly evaluated in the respective 
countries where they are to be used before they can be relied upon as diagnostic tools. 
Interfering circumstances such as medications and strain variability should be addressed in 
greater detail. Due to endemic malaria, strain variability and self medication, it is a possibility 
that the stool based test looses some of its sensitivity. As self medication is difficult to avoid, 
it is probably wise to choose a different test system for H. pylori identification in Mali.  
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Appendices A-C 
Appendix A. Confirmed gastric ulcer by gastroscopy (serological test, Clearview® H. 
pylori) 
Result Sex Age Ethnic group 
pos F 49 Bambara 
pos M 35 Bambara 
pos M 37 d.ma 
pos M 38 Bambara 
pos M 38 Minianka 
pos M 65 Peulh 
neg F 27 Dogon 
neg F 29 Bambara 
neg F 32 Sénoufo 
neg F 47 Bambara 
neg F 47 Malinké 
neg F 49 Bambara 
neg F 50 Bambara 
neg F 51 Bambara 
neg F 52 Peulh 
neg F 55 Peulh 
neg M 23 Forgeron 
neg M 24 Peulh 
neg M 27 Sonrhaï 
neg M 28 Peulh 
neg M 32 Bambara 
neg M 35 Dafing 
neg M 40 Peulh 
neg M 40 Peulh 
neg M 41 Sénoufo 
neg M 42 Sénoufo 
neg M 43 Malinké 
neg M 46 Somono 
neg M 63 Peulh 
a data is missing 
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Appendix B. Randomly selected volunteers (serological test, Clearview® H. pylori) 
Result Sex Age 
Ethnic 
group 
Gastroscopy 
in the past Gastric problems and treatment 
pos F 20 Malinké no 
Sometimes. Uses aspirin, 
diclophenac, paracetamol. 
pos F 23 Bozo no 
Painful when eating, not 
frequently. 
pos F 24 Tamasheq no Reflux problems, not every week. 
pos F 25 Sonrhaï no Burning feeling in upper gut. 
pos F 26 Sarakolé no No problems. 
pos F 33 d.ma no 
Gastric problems. Uses 
metronidazol, amoxicillin and 
omeproazole. 
pos F 33 Sonrhaï no No problems. 
pos F 34 Peuhl no 
Stomach ache once a month. Uses 
the traditional drug Filafinh (a 
carbonized powder of a tree). 
pos F 36 Malinké no 
Reflux when she eats a lot, or not 
eating at all. Uses amoxicillin and 
antacid. 
pos F 43 Fofana no 
Reflux when hungry. Uses 
Gastrosedal  twice a week 
pos F 44 Sarakolé no 
Reflux, not frequently. Uses 
antacid.  
pos F 50 Sarakolé 2003 
Reflux when eating a lot or not at 
all. Perhaps ulcer. Uses 
omeprazole or lansoprazole, and 
antacid. 
pos F 52 d.m yes Omeprazole and antacid. 
pos M 20 d.m no No problems. 
pos M 20 Dafing no No problems. 
pos M 20 Sonrhaï no No problems. 
pos M 20 Sonrhaï no No problems. 
pos M 27 Bambara no No problems. 
pos M 27 d.m no Reflux when hungry, eating helps.  
pos M 27 Sénoufo no 
Pain when hungry. Has used 
antacid. 
pos M 27 Sénoufo no No problems. 
pos M 35 Sangaré no No problems. 
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pos M 39 Sénoufo no 
Chronic constipation, uses Laxa 
cassia twice a week 
pos M 47 Bambara no No problems. 
pos M 49 Sénoufo no No problems. 
pos M 50 Peuhl no No problems. 
neg F 25 Bozo 2003 Did not have gastric ulcer. 
neg F 25 Fofana no No problems. 
neg F 25 Minianka no Reflux when eating greasy food. 
neg F 27 Sarakolé 2008 
Perhaps ulcer. Uses antacid and 
antibiotic when the pain starts. 
neg F 28 Malinké no No problems. 
 
neg 
F 29 Bambara 2003 
Conventional treatment 2003, now 
Gastrosedal. 
neg F 29 Sonrhaï 2003 
Conventional treatment for gastric 
ulcer in 2003. 
neg F 30 Peuhl no 
Possible gastritis. Uses omeprazole 
and antacid. 
neg F 34 Sonrhaï no Reflux problems, use antacid. 
neg F 35 Malinké no 
Reflux when eating a lot or not at 
all. Uses antacid. 
neg F 41 Haoussa no 
Reflux, when eating a lot, or not at 
all. Uses antacid when problems 
(not frequently). 
neg F 42 Sarakolé no No problems. 
neg F 48 Bambara no No problems. 
neg F 48 Bambara no 
Reflux not frequently. Uses 
Gastrosedal. 
neg F 48 Malinké no No problems. 
neg F 51 Malinké no 
Reflux when eating a lot or not at 
all. Uses antacid.   
neg F 62 Kakolo 2007 
Reflux, not frequently. Uses 
antacid. 
neg F 65 Sarakolé 2006 
Reflux, twice every month, when 
eating a lot or not at all. 
neg F 70 Samôgô no 
Possible a gastric ulcer, uses 
antacid. 
neg M 18 Bambara no No problems. 
neg M 18 Bambara no No problems. 
neg M 19 Sonrhaï no No problems. 
neg M 21 Bambara no No problems. 
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neg M 22 Bambara no 
Stomach ache, but not ulcer. Uses 
aspirin. 
neg M 22 Bambara no No problems. 
neg M 26 Minianka no 
Reflux once a week. Uses the 
traditional drug Diababoulouba. 
neg M 28 Sénoufo no 
Reflux problems, 3 times a week, 
no treatment. 
neg M 41 Bambara no 
Reflux problems when hungry. 
Uses Gastrosedal twice a week. 
neg M 50 Peuhl no 
Reflux when not eating during 
Ramadan. 
neg M 53 Bambara no No problems. 
neg M 56 Malinké no 
Conventional treatment for gastric 
ulcer. 
neg M 60 Bambara 1998 
Conventional treatment for gastric 
ulcer in 1998, but has still 
problems. 
neg M 63 Peuhl 2008 
Reflux, not frequently. Does not 
have ulcer. Uses traditional 
medicine. 
a data is missing 
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Appendix C. Volunteers seeking help for diverse gastric ailments (stool test, ImmunoCard 
STAT!® HpSA®). 
Result Sex Age Ethnic group Reason for giving stool 
pos F 24 Sarakolé Possible infection 
pos F 37 Peulh d.ma 
pos F 40 Kasonké Possible infection 
pos F 50 Bambara Possible infection 
pos F 52 Peulh Dysenteri 
pos F 70 Bambara Possible infection 
pos F 70 Kakolo d.m 
pos M 64 Sarakolé Possible infection 
pos M d.m. Kasonké Prurigo 
neg d.m. d.m. d.m Urticaria 
neg F 4 Sarakolé Abdominal pain 
neg F 8 Sonhraï d.m 
neg F 9 Sarakolé Abdominal pain 
neg F 11 Sarakolé Abdominal pain 
neg F 15 Sarakolé Abdominal pain 
neg F 16 Bambara Dermatosis 
neg F 17 Sarakolé Possible infection 
neg F 18 Dogon Abdominal pain 
neg F 22 Dogon Possible infection 
neg F 24 Sarakolé Possible parasitic disease  
neg F 25 Kakolo Dermatosis 
neg F 29 Peulh d.m 
neg F 30 Kasonké d.m 
neg F 30 Peulh Possible infection 
neg F 31 Sarakolé Possible infection 
neg F 35 Malinké Leukorrhea 
neg F 35 Sarakolé Possible infection 
neg F 37 Bambara Possible infection 
neg F 39 Bambara d.m 
neg F 40 Sarakolé Abdominal pain 
neg F 41 Peulh Possible infection 
neg F 43 Peulh d.m 
neg F 45 Peulh Constipation 
neg F 47 Malinké Possible infection 
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neg F 62 Sarakolé Constipation 
neg M 2 Peulh Circle cell anemia 
neg M 4 Sarakolé Possible infection 
neg M 6 Maure Possible infection 
neg M 6 Sarakolé d.m 
neg M 8 Peulh d.m 
neg M 9 Malinké Abdominal pain 
neg M 17 Bambara Abdominal pain 
neg M 20 Bambara Possible infection 
neg M 21 Senoufo d.m 
neg M 24 Peulh d.m 
neg M 27 Minianka d.m 
neg M 28 Bambara Abdominal pain 
neg M 28 Dogon Possible parasitic disease  
neg M 30 d.m d.m 
neg M 31 Somono Abdominal pain 
neg M 34 Dogon d.m 
neg M 34 Sarakolé d.m 
neg M 34 Sonhraï Possible infection 
neg M 36 Malinké d.m 
neg M 39 Peulh d.m 
neg M 49 Bambara d.m 
neg M 52 Sarakolé d.m 
neg M 53 Bambara Possible infection 
neg M 58 Bambara d.m 
neg M 63 Kassonké Diarrhoea 
neg M 70 Peulh Abdominal pain 
neg M d.m. Bambara Possible infection 
neg M d.m. Peulh Possible infection 
neg M d.m. Sénoufo Abdominal pain 
a data is missing 
 
 
  
 
